Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17747
Country/Region: Nigeria
Year: 2017
Main Partner: Henry M. Jackson Foundation for the Advancement of Military Medicine
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $0 Additional Pipeline Funding: $5,080,974

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Prevention: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2018 231
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 99
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2018 231
GEND_GBV_DSD Number of people receiving post-GBV care 2018 330
HTC_TST_DSD By Key Population: FSW, Negative 2018 3,770
HTC_TST_DSD By Key Population: FSW, Positive 2018 87
HTC_TST_DSD By Key Population: MSM, Negative 2018 8,192
HTC_TST_DSD By Key Population: MSM, Positive 2018 850
HTC_TST_DSD By Key Population: PWID, Negative 2018 1,814
HTC_TST_DSD By Key Population: PWID, Positive 2018 22
HTC_TST_DSD By Test Result: Positive 2018 8,964
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 147,846
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 401
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 134
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 341
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 114
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 47,213
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 1,172
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 477
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 12
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 1,028
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 127
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 875
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 108
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 13
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 2
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 11
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 1
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 35,751
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 3,318
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 30,455
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 2,826
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 982
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 85
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 837
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 73
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 842
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 223
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 717
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 191
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 20
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 9
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 17
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 7
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 216
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 19
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 184
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 16
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 4,626
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 132
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 13,878
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 395
HTC_TST_DSD Sum of Test Result disaggregates 2018 8,964
KP_PREV_DSD By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 3,857
KP_PREV_DSD By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 294
KP_PREV_DSD By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 1,542
KP_PREV_DSD By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 9,042
KP_PREV_DSD Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 14,735
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 306
PMTCT_ART_DSD New on ART 2018 1,142
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,448
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 49,214
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,448
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 467
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 971
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 3
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 7
PMTCT_STAT_DSD By Age (Denominator): 10-14 2018 5
PMTCT_STAT_DSD By Age (Denominator): 20-24 2018 9,325
PMTCT_STAT_DSD By Age (Denominator): 25-49 2018 40,251
PMTCT_STAT_DSD By Age (Denominator): 50+ 2018 824
PMTCT_STAT_DSD By Age (Denominator): <15-19 2018 1,399
PMTCT_STAT_DSD By Age (Numerator): 10-14 2018 5
PMTCT_STAT_DSD By Age (Numerator): 15-19 2018 1,329
PMTCT_STAT_DSD By Age (Numerator): 20-24 2018 8,859
PMTCT_STAT_DSD By Age (Numerator): 25-49 2018 38,238
PMTCT_STAT_DSD By Age (Numerator): 50+ 2018 783
PMTCT_STAT_DSD By Number of known positives: 15-19 2018 9
PMTCT_STAT_DSD By Number of known positives: 20-24 2018 61
PMTCT_STAT_DSD By Number of known positives: 25-49 2018 264
PMTCT_STAT_DSD By Number of known positives: 50+ 2018 5
PMTCT_STAT_DSD By Number of new negative: 10-14 2018 5
PMTCT_STAT_DSD By Number of new negative: 15-19 2018 1,288
PMTCT_STAT_DSD By Number of new negative: 20-24 2018 8,584
PMTCT_STAT_DSD By Number of new negative: 25-49 2018 37,055
PMTCT_STAT_DSD By Number of new negative: 50+ 2018 759
PMTCT_STAT_DSD By Number of new positives: 15-19 2018 32
PMTCT_STAT_DSD By Number of new positives: 20-24 2018 213
PMTCT_STAT_DSD By Number of new positives: 25-49 2018 920
PMTCT_STAT_DSD By Number of new positives: 50+ 2018 19
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 49,214
PrEP_NEW_DSD Female 20-24 2018 53
PrEP_NEW_DSD Female 25-49 2018 131
PrEP_NEW_DSD Female 50+ 2018 79
PrEP_NEW_DSD FSW 2018 263
PrEP_NEW_DSD Male 20-24 2018 157
PrEP_NEW_DSD Male 25-49 2018 394
PrEP_NEW_DSD Male 50+ 2018 236
PrEP_NEW_DSD MSM 2018 755
PrEP_NEW_DSD Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2018 1,050
PrEP_NEW_DSD TG 2018 32
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 22
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 20
TB_ART_DSD Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 13
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 11
TB_ART_DSD Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 37
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 33
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2018 20,593
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2018 8,210
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2018 747
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2018 772
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2018 14,415
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2018 5,747
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2018 523
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2018 541
TB_PREV_DSD By Therapy type (Denominator): 6-12 Month IPT 2018 30,322
TB_PREV_DSD By Therapy type (Numerator): 6-12 Month IPT 2018 21,226
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 21,226
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 30,322
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 66
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 60
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 17
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 15
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 66
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 60
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 16
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 14
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 149
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 165
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2018 20,140
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2018 11,037
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2018 540
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2018 540
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 32,257
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2018 31,177
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2018 1,080
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2018 32,257
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2018 4,126
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2018 2,982
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2018 100
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2018 100
TX_NEW_DSD Breastfeeding status 2018 12
TX_NEW_DSD By Key populations: People who inject drugs (PWID) 2018 19
TX_NEW_DSD FSW 2018 79
TX_NEW_DSD MSM 2018 765
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 7,308
TX_NEW_DSD Pregnancy status 2018 206
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2018 7,308
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 11,937
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,107
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 6,526
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,152
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 365
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 64
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 365
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 64
TX_PVLS_DSD Denominator: Indication: Routine 2018 19,193
TX_PVLS_DSD Denominator: Indication: Targeted 2018 3,387
TX_PVLS_DSD Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 38
TX_PVLS_DSD Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 7
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Routine 2018 633
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Targeted 2018 112
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 22,580
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 20,322
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 10,744
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,896
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 5,874
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,036
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 328
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 58
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 328
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 58
TX_PVLS_DSD Numerator: Indication: Routine 2018 17,274
TX_PVLS_DSD Numerator: Indication: Targeted 2018 3,048
TX_PVLS_DSD Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 35
TX_PVLS_DSD Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 6
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Routine 2018 570
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Targeted 2018 101
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 19,392
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 17,453
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 10,601
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,541
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 592
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 533
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 592
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 533
TX_RET_DSD Denominator by Status: Breastfeeding 2018 62
TX_RET_DSD Denominator by Status: Pregnant 2018 1,029
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 28,060
TX_RET_DSD Numerator by Status: Breastfeeding 2018 56
TX_RET_DSD Numerator by Status: Pregnant 2018 926
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 31,177
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2018 37
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2018 37
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2018 1,204
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2018 657
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 1,548
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 387
TX_TB_DSD Denominator: By Screen Result: Negative 2018 1,451
TX_TB_DSD Denominator: By Screen Result: Positive 2018 484
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 1,935
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2018 1,935
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 1,935
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 1,204
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 657
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Female 2018 37
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Male 2018 37